Literature DB >> 21686854

Oxaliplatin-induced coronary artery spasm: first report of an important side-effect.

Jens Samol1, Ashita Waterston.   

Abstract

A 67-year-old woman with metastatic colorectal cancer was given her first oxaliplatin infusion as part of the XELOX protocol. She developed chest pain with ECG changes leading subsequently to a diagnosis of coronary artery spasm. To our knowledge, this is the first report of oxaliplatin-induced coronary artery spasm.

Entities:  

Year:  2009        PMID： 21686854      PMCID： PMC3028146          DOI： 10.1136/bcr.06.2008.0334

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  12 in total

1.  Hürthle cell carcinoma: a critical histopathologic appraisal.

Authors:  A Stojadinovic; R A Ghossein; A Hoos; M J Urist; R H Spiro; J P Shah; M F Brennan; A R Shaha; B Singh
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

Review 2.  Oxaliplatin-related neurotoxicity: how and why?

Authors:  Lara Maria Pasetto; Mario Rosario D'Andrea; Elena Rossi; Silvio Monfardini
Journal:  Crit Rev Oncol Hematol       Date:  2006-06-27       Impact factor: 6.312

3.  Oxaliplatin-induced neurotoxicity and the development of neuropathy.

Authors:  Arun V Krishnan; David Goldstein; Michael Friedlander; Matthew C Kiernan
Journal:  Muscle Nerve       Date:  2005-07       Impact factor: 3.217

4.  [Cerebral infarction and myocardial infarction due to cisplatin-containing chemotherapy].

Authors:  M E E Brouha; H J Bloemendal; L J Kappelle; J B Winter
Journal:  Ned Tijdschr Geneeskd       Date:  2003-03-08

5.  Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.

Authors:  K Egashira; T Inou; Y Hirooka; A Yamada; Y Urabe; A Takeshita
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

6.  Angina pectoris. I. A variant form of angina pectoris; preliminary report.

Authors:  M PRINZMETAL; R KENNAMER; R MERLISS; T WADA; N BOR
Journal:  Am J Med       Date:  1959-09       Impact factor: 4.965

7.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

Review 8.  Cardiotoxicity of 5-fluorouracil.

Authors:  P Alter; M Herzum; M Soufi; J R Schaefer; B Maisch
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2006-01

9.  Cardiac sodium channel mutation in atrial fibrillation.

Authors:  Patrick T Ellinor; Edwin G Nam; Marisa A Shea; David J Milan; Jeremy N Ruskin; Calum A MacRae
Journal:  Heart Rhythm       Date:  2007-09-19       Impact factor: 6.343

Review 10.  Coronary artery spasm: a review.

Authors:  D R Richmond
Journal:  J R Soc Med       Date:  1980-08       Impact factor: 18.000
View more
  2 in total

1.  PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin.

Authors:  Linlin Wu; Changjun Man; Hong Wang; Xiaohe Lu; Qinghai Ma; Yu Cai; Wanshan Ma
Journal:  Pharm Res       Date:  2012-09-20       Impact factor: 4.200

2.  Case Report: Oxaliplatin-Induced Third-Degree Atrioventricular Block: First Discovery of an Important Side-Effect.

Authors:  Xi Chen; Hui Wang; Zijin Zhang; Yan Xu; Xuanqi An; Xin Ai; Lin Li
Journal:  Front Cardiovasc Med       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.